@article{a1ffcbdd9361414ca7cbc9d59e6268af,
title = "The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry",
keywords = "hospital-based registry, mastocytosis, multidisciplinary management, cladribine, corticosteroid, dasatinib, gamma interferon, imatinib, nilotinib, stem cell factor receptor, tryptase, adolescent, adult, anaphylaxis, Article, bone marrow biopsy, child, disease registry, female, gene, human, Italy, KIT gene, major clinical study, male, overall survival, prevalence, priority journal, progression free survival, stomach disease, systemic mastocytosis, urticaria pigmentosa",
author = "S. Merante and V.V. Ferretti and C. Elena and V. Brazzelli and R. Zanotti and I. Ner and D. Magliacane and {Belloni Fortina}, A. and F. Ingeborg and E.A. Pastorello and L. Pieri and C. Papayannidis and M. Mauro and F. Grifoni and R. Minelli and E. Guggiari and E. Difonzo and M. Bocchia and F. Caroppo and {Di Nuzzo}, S. and E.M. Elli and M. Rondoni and R. Ciccocioppo and {Di Stefano}, M. and G. Bossi and E. Boveri and P. Bonadonna and F. Giona and P. Valent and M. Triggiani",
note = "Cited By :1 Export Date: 18 January 2019 Correspondence Address: Merante, S.; Hematology, Fondazione IRCCS Policlinico San MatteoItaly; email: serenamerante@alice.it",
year = "2018",
doi = "10.2217/fon-2018-0291",
language = "English",
volume = "14",
pages = "2713--2723",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "26",
}